Health and social work services

Tender description

NHS England Specialised Commissioning (The Commissioner) is planning to commission organisations to provide the Thrombotic Thrombocytopenic Purpura (TTP) for the population of England. This notice is to advise prospective providers of the Commissioner’s intention, and opportunities to engage and participate in a dedicated WebEx Market Engagement Event. TTP is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate (and in the case of congenital TTP, ongoing) management in a centre with comprehensive provision and a multi-discipline approach. Specialist led coordinated care is key to improving outcomes for this patient group. For more information and to register for the WebEx market engagement event on 24.2.2020 please complete the short questionnaire on EU Supply by using the following link https://uk.eu-supply.com/login.asp?B=agcsu (referenced as Quote/tender 39021). Aim of service: The service objectives are to: — improve the identification of patients with this disease, — improve the time to treatment and management of the patients and improve their outcomes, — provide a specialised centre that can provide expert led care, — reduce the mortality from this disease, — ensure patients have a positive experience of care, — manage the ongoing long-term care and potential relapse, — maintain and encourage patients own family/friend support (patient led), — improve times from diagnosis to treatment including bed availability, line insertion and start of apheresis, — ensure infrastructure of staff to undertake this process e.g. consultant haematologists and CNS, — ensure dedicated PAs by a clinical psychologist to support in patient care and outpatient follow up to capture depression/anxiety (in approximately 50 % patients) and support return to normal activities pre TTP, — support patient groups who will also carry out independent patient satisfaction exercises and invite them to join the national annual highly specialised audit meeting to present this work to other services and commissioners, — at the highly specialised service annual clinical meeting identify changes in the service based on patient feedback. Objectives of project: The objectives of the procurement for this service are to: — fully implement the service provision as described in the adopted service specification, — ensure that appointed centres have the capacity and capability to provide the service to the required quality and outcomes, — provide appropriate access in the UK for patients with TTP. Link to draft service specification and related consultation documents: The draft service specification can be found at: https://www.engage.england.nhs.uk/consultation/thrombocytopenic-purpura/ The future opportunity will be advertised and procured on the basis of the current NHS Standard Contract. The service is expected to commence in October — November 2020. The procurement will be in accordance with the Public Contracts Regulations 2015 (the ‘Regulations’), Schedule 3 — Social and Other Specific Services.